- Home
- Publications
- Publication Search
- Publication Details
Title
The molecular regulation of Janus kinase (JAK) activation
Authors
Keywords
-
Journal
BIOCHEMICAL JOURNAL
Volume 462, Issue 1, Pages 1-13
Publisher
Portland Press Ltd.
Online
2014-07-24
DOI
10.1042/bj20140712
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation
- (2014) Camilla Pilati et al. CANCER CELL
- Tofacitinib for acute rheumatoid arthritis patients who have had an inadequate response to disease-modifying antirheumatic drug (DMARD): a systematic review and meta-analysis
- (2014) Xingming Zhang et al. CLINICAL RHEUMATOLOGY
- Selective deletion of Jak2 in adult mouse hematopoietic cells leads to lethal anemia and thrombocytopenia
- (2014) J. Grisouard et al. HAEMATOLOGICA
- Structural basis of recognition of interferon-α receptor by tyrosine kinase 2
- (2014) Heidi J A Wallweber et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition
- (2014) P. J. Lupardus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
- (2014) A. J. Brooks et al. SCIENCE
- Critical Role of Jak2 in the Maintenance and Function of Adult Hematopoietic Stem Cells
- (2014) Hajime Akada et al. STEM CELLS
- Conditional ablation of TYK2 in immunity to viral infection and tumor surveillance
- (2014) Raimund M. Vielnascher et al. TRANSGENIC RESEARCH
- SUMOylation is a regulator of the translocation of Jak2 between nucleus and cytosol
- (2013) Magdalena Sedek et al. BIOCHEMICAL JOURNAL
- Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses
- (2013) Leila N. Varghese et al. BIOCHEMICAL JOURNAL
- A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties
- (2013) James M. Murphy et al. BIOCHEMICAL JOURNAL
- The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
- (2013) James M. Murphy et al. IMMUNITY
- Structure-guided studies of the SHP-1/JAK1 interaction provide new insights into phosphatase catalytic domain substrate recognition
- (2013) Nilda L. Alicea-Velázquez et al. JOURNAL OF STRUCTURAL BIOLOGY
- On the Regulation and Activation of JAK2: A Novel Hypothetical Model
- (2013) Tai-Sung Lee MOLECULAR CANCER RESEARCH
- Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases
- (2013) Angela V Toms et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition
- (2013) Nadia J Kershaw et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans
- (2013) Sung O. Park et al. PLoS One
- Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling
- (2013) I. Louria-Hayon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia
- (2012) M. Porcu et al. BLOOD
- Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
- (2012) M. L. Loh et al. BLOOD
- The biology and mechanism of action of suppressor of cytokine signaling 3
- (2012) Jeffrey J. Babon et al. GROWTH FACTORS
- Genotype-Phenotype Interactions in the Myeloproliferative Neoplasms
- (2012) Anna L. Godfrey et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Suppression of Cytokine Signaling by SOCS3: Characterization of the Mode of Inhibition and the Basis of Its Specificity
- (2012) Jeffrey J. Babon et al. IMMUNITY
- A Patient with Tyrosine Kinase 2 Deficiency without Hyper-IgE Syndrome
- (2012) Sara S. Kilic et al. JOURNAL OF PEDIATRICS
- Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
- (2012) Priya Koppikar et al. NATURE
- Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F
- (2012) Rajintha M Bandaranayake et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
- (2011) F. Passamonti et al. BLOOD
- Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
- (2011) J. Zhang et al. BLOOD
- PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia
- (2011) M. Kleppe et al. BLOOD
- JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth
- (2011) Fouad A. Zouein et al. GROWTH FACTORS
- The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3
- (2011) M. Vogt et al. JOURNAL OF CELL SCIENCE
- The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
- (2011) Daniela Ungureanu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural Snapshots of Full-Length Jak1, a Transmembrane gp130/IL-6/IL-6Rα Cytokine Receptor Complex, and the Receptor-Jak1 Holocomplex
- (2011) Patrick J. Lupardus et al. STRUCTURE
- PTP1B Suppresses Prolactin Activation of Stat5 in Breast Cancer Cells
- (2010) Kevin J. Johnson et al. AMERICAN JOURNAL OF PATHOLOGY
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- (2010) S. T. Oh et al. BLOOD
- Oncogenic JAK2V617F requires an intact SH2-like domain for constitutive activation and induction of a myeloproliferative disease in mice
- (2010) S. P. Gorantla et al. BLOOD
- Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms
- (2010) F. Baran-Marszak et al. BLOOD
- Tyrosines 868, 966, and 972 in the Kinase Domain of JAK2 Are Autophosphorylated and Required for Maximal JAK2 Kinase Activity
- (2010) Lawrence S. Argetsinger et al. MOLECULAR ENDOCRINOLOGY
- Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
- (2010) Maria Kleppe et al. NATURE GENETICS
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK2 V617F Constitutive Activation Requires JH2 Residue F595: A Pseudokinase Domain Target for Specific Inhibitors
- (2010) Alexandra Dusa et al. PLoS One
- A JAK2 Interdomain Linker Relays Epo Receptor Engagement Signals to Kinase Activation
- (2009) Lequn Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of Jak2 Function by Phosphorylation of Tyr317 and Tyr637 during Cytokine Signaling
- (2009) S. A. Robertson et al. MOLECULAR AND CELLULAR BIOLOGY
- JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
- (2009) Mark A. Dawson et al. NATURE
- JAK mutations in high-risk childhood acute lymphoblastic leukemia
- (2009) C. G. Mullighan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
- (2008) G. Wernig et al. BLOOD
- Negative regulation of Jak2 by its auto-phosphorylation at tyrosine 913 via the Epo signaling pathway
- (2008) Megumi Funakoshi-Tago et al. CELLULAR SIGNALLING
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
- (2008) E. G. Jeong et al. CLINICAL CANCER RESEARCH
- Somatically acquiredJAK1mutations in adult acute lymphoblastic leukemia
- (2008) Elisabetta Flex et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias
- (2008) Wanlong Ma et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
- (2008) Dani Bercovich et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now